If you have suffered a loss on your DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DCXM) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected], or fill out ...
Lead Plaintiff Deadline is December 26, 2025 NEW YORK, Nov. 11, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that ...
Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action in the U.S. District Court for the Southern District of New York alleging violations ...
Insulet reported Omnipod revenue of $699.2 million for the third quarter of 2025, up 31% over the same quarter in 2024 ...
The Tandem Mobi app will be downloadable from the Google Play Store on compatible smartphones, including Google Pixel and ...
Investor's Business Daily on MSN
The Wild Ride That Sent IBD Stock Of The Day Insulet Into An Early Breakout
Insulet is Thursday's IBD Stock Of The Day. After a wild post-earnings reaction, Insulet stock is in a consolidation with an ...
Zacks Investment Research on MSN
Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
Insulet Corporation PODD reported third-quarter 2025 adjusted earnings per share (EPS) of $1.24, up 37.8% from the year-ago ...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the ...
Carrot announced that it partnered with Oura and Dexcom to deliver actionable, personalized insights supporting fertility ...
The CGM market is expected to experience double-digit percentage growth over the next five years, reaching nearly $29 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback